Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Ajanta Pharma Limited | Bharuch, India | Makes it | No problems foundJun 23, 2023 · 3 inspections |
Recalls
- Sep 17, 2026 · Class II · Ajanta Pharma USA Inc
Failed Dissolution Specifications: below specification
Lots: Lot: DJ25134, Exp 11/30/2028
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ranolazine: every company that makes it
- Form
- tablet, extended release, oral
- Strength
- 1000 mg
- Approval
- ANDA ANDA210054
- On the market since
- Aug 23, 2019
- Package NDCs
27241-126-0227241-126-05- Official label
- DailyMed (National Library of Medicine), updated Oct 28, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?